目录肽产品
CPEP-001A
C-Peptide, human
Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln
Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln
Size：0.5
P1(RMB)：490
MW：3020.3
One letter sequence：EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ
Molecular Formula：C129H211N35O48
Description：This C-peptide measurement can sensitively assess β-cell functions under standardized conditions, which is the most suitable primary outcome for clinical trials of therapies aimed at preserving or improving preserving endogenous insulin secretion in type 1 diabetes patients.
Literature Reference：A.S.C. Ko and D.G. Smyth, Eur. J. Biochem., 20, 190 (1971)\nP.E. Oyer et al., J. Biol. Chem., 246, 1375 (1971)\nK. Igano et al., Bull. Chem. Soc. Jpn., 54, 3088 (1981)
Cas：[33017-11-7]
P1(RMB)：490
MW：3020.3
One letter sequence：EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ
Molecular Formula：C129H211N35O48
Description：This C-peptide measurement can sensitively assess β-cell functions under standardized conditions, which is the most suitable primary outcome for clinical trials of therapies aimed at preserving or improving preserving endogenous insulin secretion in type 1 diabetes patients.
Literature Reference：A.S.C. Ko and D.G. Smyth, Eur. J. Biochem., 20, 190 (1971)\nP.E. Oyer et al., J. Biol. Chem., 246, 1375 (1971)\nK. Igano et al., Bull. Chem. Soc. Jpn., 54, 3088 (1981)
Cas：[33017-11-7]
